B cell expression of FcγRIIb (CD32) (MFI) was also significantly lower in patients with RA compared with those with SLE, with median (IQR) 280 (181–555) and 2414 (1378–5707), respectively. This evidence concerns the gene FCGR2B and systemic lupus erythematosus.